Advertisement

Obstetric History and Cardiovascular Disease (CVD) Risk

  • Eleni Armeni
  • Evangelia Karopoulou
  • Irene LambrinoudakiEmail author
Chapter
Part of the ISGE Series book series (ISGE)

Abstract

During normal pregnancy, several metabolic and hemodynamic alterations occur in order to ensure normal fetal development. A pregnant woman’s failure to overcome these alterations may result in hypertensive pregnancy disorders (gestational hypertension, preeclampsia/eclampsia) or gestational diabetes mellitus. Recent studies have shown that these complications not only affect the pregnancy outcome but are also related to vascular dysfunction that persists postpartum. Moreover, there is an established association between hypertensive pregnancy disorders, gestational diabetes mellitus, and subsequent risk of cardiovascular disease (CVD) later in life. Despite the numerous data that support this association, most obstetricians and primary healthcare physicians dot not provide appropriate postpartum follow-up and counseling to women with increased risk of CVD. Lifestyle modifications in association with close follow-up applied early after labor in women with complicated pregnancies may provide early diagnosis and prevention of future cardiovascular events. Therefore, it is essential for the physicians to understand the importance of obstetric history as a predictive factor of CVD and incorporate it in the daily practice in order to optimize the management of women with increased CVD risk and subsequently reduce CVD rates in women.

Keywords

Obstetric history Pregnancy complications Hypertensive pregnancy disorders Preeclampsia Gestational diabetes mellitus Cardiovascular disease 

References

  1. 1.
    WHO. Cardiovascular disease key facts. Geneva: WHO. www.who.int/mediacentre/factsheets/fs317/en/. Accessed 27 Feb 2018.
  2. 2.
    Townsend N, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45.CrossRefGoogle Scholar
  3. 3.
    Appelman Y, et al. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211–8.CrossRefGoogle Scholar
  4. 4.
    Park K, et al. Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child. Cardiovasc Drugs Ther. 2015;29(4):391–401.CrossRefGoogle Scholar
  5. 5.
    Mosca L, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the american heart association. Circulation. 2011;123(11):1243–62.CrossRefGoogle Scholar
  6. 6.
    Gongora MC, Wenger NK. Cardiovascular complications of pregnancy. Int J Mol Sci. 2015;16(10):23905–28.CrossRefGoogle Scholar
  7. 7.
    Lind JM, Hennessy A, McLean M. Cardiovascular disease in women: the significance of hypertension and gestational diabetes during pregnancy. Curr Opin Cardiol. 2014;29(5):447–53.CrossRefGoogle Scholar
  8. 8.
    Smith GN. The maternal health clinic: improving women’s cardiovascular health. Semin Perinatol. 2015;39(4):316–9.CrossRefGoogle Scholar
  9. 9.
    Thornburg KL, et al. Hemodynamic changes in pregnancy. Semin Perinatol. 2000;24(1):11–4.CrossRefGoogle Scholar
  10. 10.
    Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol. 2001;97(5 Pt 1):669–72.PubMedGoogle Scholar
  11. 11.
    Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin. 2012;30(3):317–29.CrossRefGoogle Scholar
  12. 12.
    Creasy RK, Resnik R. Maternal-fetal medicine. Philadelphia, PA: Saunders; 1999.Google Scholar
  13. 13.
    Tiralongo GM, et al. Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia. Pregnancy Hypertens. 2015;5(2):193–7.CrossRefGoogle Scholar
  14. 14.
    Ayala DE, et al. Blood pressure variability during gestation in healthy and complicated pregnancies. Hypertension. 1997;30(3 Pt 2):611–8.CrossRefGoogle Scholar
  15. 15.
    Grindheim G, et al. Changes in blood pressure during healthy pregnancy: a longitudinal cohort study. J Hypertens. 2012;30(2):342–50.CrossRefGoogle Scholar
  16. 16.
    James AH. Pregnancy-associated thrombosis. Hematology Am Soc Hematol Educ Program. 2009;2009:277.CrossRefGoogle Scholar
  17. 17.
    DeStephano CC, et al. Diagnosis and management of iliac vein thrombosis in pregnancy resulting from May-Thurner syndrome. J Perinatol. 2014;34(7):566–8.CrossRefGoogle Scholar
  18. 18.
    Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71(5 Suppl):1256S–61S.CrossRefGoogle Scholar
  19. 19.
    Mammaro A, et al. Hypertensive disorders of pregnancy. J Prenat Med. 2009;3(1):1–5.PubMedPubMedCentralGoogle Scholar
  20. 20.
    National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–S22.CrossRefGoogle Scholar
  21. 21.
    Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213–20.CrossRefGoogle Scholar
  22. 22.
    Groenhof TKJ, et al. Preventing cardiovascular disease after hypertensive disorders of pregnancy: searching for the how and when. Eur J Prev Cardiol. 2017;24(16):1735–45.CrossRefGoogle Scholar
  23. 23.
    Timpka S, et al. Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses’ Health Study II: observational cohort study. BMJ. 2017;358:j3024.CrossRefGoogle Scholar
  24. 24.
    Wang L, et al. Association between hypertensive disorders of pregnancy and the risk of postpartum hypertension: a cohort study in women with gestational diabetes. J Hum Hypertens. 2017;31(11):725–30.CrossRefGoogle Scholar
  25. 25.
    Behrens I, et al. Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy. JAMA. 2016;315(10):1026–33.CrossRefGoogle Scholar
  26. 26.
    Veerbeek JH, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015;65(3):600–6.CrossRefGoogle Scholar
  27. 27.
    Andersgaard AB, et al. Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study. Am J Obstet Gynecol. 2012;206(2):6.CrossRefGoogle Scholar
  28. 28.
    Kestenbaum B, et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis. 2003;42(5):982–9.CrossRefGoogle Scholar
  29. 29.
    Wikstrom AK, et al. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG. 2005;112(11):1486–91.CrossRefGoogle Scholar
  30. 30.
    Tooher J, et al. All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease. Hypertension. 2017;70(4):798–803.CrossRefGoogle Scholar
  31. 31.
    Alsnes IV, et al. A population-based study of associations between preeclampsia and later cardiovascular risk factors. Am J Obstet Gynecol. 2014;211(6):17.CrossRefGoogle Scholar
  32. 32.
    Drost JT, et al. Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM). Eur J Prev Cardiol. 2012;19(5):1138–44.CrossRefGoogle Scholar
  33. 33.
    Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986;155(5):1011–6.CrossRefGoogle Scholar
  34. 34.
    Bokslag A, et al. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstet Gynecol. 2017;216(5):14.CrossRefGoogle Scholar
  35. 35.
    Brown MC, et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1–19.CrossRefGoogle Scholar
  36. 36.
    Wu P, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2):22.CrossRefGoogle Scholar
  37. 37.
    Zoet GA, et al. Cardiovascular RiskprofilE – IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study. BMC Womens Health. 2017;17:60.CrossRefGoogle Scholar
  38. 38.
    Hauspurg A, et al. Adverse pregnancy outcomes and future maternal cardiovascular disease. Clin Cardiol. 2018;15(10):22887.Google Scholar
  39. 39.
    Egan AM, et al. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia. 2017;60(10):1913–21.CrossRefGoogle Scholar
  40. 40.
    Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012;8(11):639–49.CrossRefGoogle Scholar
  41. 41.
    Li LJ, et al. Effect of gestational diabetes and hypertensive disorders of pregnancy on postpartum cardiometabolic risk. Endocr Connect. 2018;14:17–0359.Google Scholar
  42. 42.
    Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ. 2009;181(6–7):371–6.CrossRefGoogle Scholar
  43. 43.
    Tobias DK, et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med. 2017;177(12):1735–42.CrossRefGoogle Scholar
  44. 44.
    Goueslard K, et al. Early cardiovascular events in women with a history of gestational diabetes mellitus. Cardiovasc Diabetol. 2016;15(15):016–0338.Google Scholar
  45. 45.
    Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008;31(8):1668–9.CrossRefGoogle Scholar
  46. 46.
    Li J-W, et al. Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis. BMC Cardiovasc Disord. 2014;14:132.CrossRefGoogle Scholar
  47. 47.
    Li JW, et al. Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis. BMC Cardiovasc Disord. 2014;14(132):1471–2261.Google Scholar
  48. 48.
    Caliskan M, et al. Does gestational diabetes history increase epicardial fat and carotid intima media thickness? Echocardiography. 2014;31(10):1182–7.CrossRefGoogle Scholar
  49. 49.
    Gunderson EP, et al. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study. J Am Heart Assoc. 2014;3(2):000490.CrossRefGoogle Scholar
  50. 50.
    Lekva T, et al. Aortic stiffness and cardiovascular risk in women with previous gestational diabetes mellitus. PLoS One. 2015;10(8):e0136892.CrossRefGoogle Scholar
  51. 51.
    Vilmi-Kerala T, et al. Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study. Cardiovasc Diabetol. 2017;16(1):017–0530.CrossRefGoogle Scholar
  52. 52.
    Tam WH, et al. PP103. Arterial stiffness in women with previous GDM – a follow up of Chinese HAPO study cohort. Pregnancy Hypertens. 2012;2(3):13.CrossRefGoogle Scholar
  53. 53.
    Vural M, et al. Evaluation of the future atherosclerotic heart disease with oxidative stress and carotid artery intima media thickness in gestational diabetes mellitus. Endocr Res. 2012;37(3):145–53.CrossRefGoogle Scholar
  54. 54.
    Salmi AA, et al. Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus. Vasa. 2012;41(2):96–104.CrossRefGoogle Scholar
  55. 55.
    Lobo TF, et al. Impaired Treg and NK cells profile in overweight women with gestational diabetes mellitus. Am J Reprod Immunol. 2018;79(3):5.CrossRefGoogle Scholar
  56. 56.
    Perrine CG, et al. Lactation and maternal cardio-metabolic health. Annu Rev Nutr. 2016;36:627–45.CrossRefGoogle Scholar
  57. 57.
    Ram KT, et al. Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife—SWAN, the study of women’s health across the nation. Am J Obstet Gynecol. 2008;198(3):268.e1–6.CrossRefGoogle Scholar
  58. 58.
    Schwarz EB, et al. Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol. 2009;113(5):974–82.CrossRefGoogle Scholar
  59. 59.
    Gunderson EP, et al. Lactation duration and midlife atherosclerosis. Obstet Gynecol. 2015;126(2):381–90.CrossRefGoogle Scholar
  60. 60.
    McClure CK, et al. Lactation and maternal subclinical cardiovascular disease among premenopausal women. Am J Obstet Gynecol. 2012;207(1):2.CrossRefGoogle Scholar
  61. 61.
    Schwarz EB, et al. Lactation and maternal measures of subclinical cardiovascular disease. Obstet Gynecol. 2010;115(1):41–8.CrossRefGoogle Scholar
  62. 62.
    Groer MW, et al. Breastfeeding status and maternal cardiovascular variables across the postpartum. J Women’s Health. 2013;22(5):453–9.CrossRefGoogle Scholar
  63. 63.
    Park S, Choi NK. Breastfeeding and maternal hypertension. Am J Hypertens. 2018;25:4825441.Google Scholar
  64. 64.
    Lupton SJ, et al. Association between parity and breastfeeding with maternal high blood pressure. Am J Obstet Gynecol. 2013;208(6):7.CrossRefGoogle Scholar
  65. 65.
    Peters SA, et al. Parity, breastfeeding and risk of coronary heart disease: a pan-European case-cohort study. Eur J Prev Cardiol. 2016;23(16):1755–65.CrossRefGoogle Scholar
  66. 66.
    Peters SAE, et al. Breastfeeding and the risk of maternal cardiovascular disease: a prospective study of 300 000 Chinese women. J Am Heart Assoc. 2017;6(6):006081.CrossRefGoogle Scholar
  67. 67.
    Natland Fagerhaug T, et al. A prospective population-based cohort study of lactation and cardiovascular disease mortality: the HUNT study. BMC Public Health. 2013;13(1070):1471–2458.Google Scholar

Copyright information

© International Society of Gynecological Endocrinology 2019

Authors and Affiliations

  • Eleni Armeni
    • 1
  • Evangelia Karopoulou
    • 1
  • Irene Lambrinoudaki
    • 1
    Email author
  1. 1.2nd Department of Obstetrics and Gynecology, Medical SchoolNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations